RONALD BEASLEY: Open Payments
NPI 1790186625 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 21 payments from 13 companies in 2025. Trend: 2023 $547 · 2024 $672 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $68 |
| Lilly USA, LLC | 3 | $67 |
| Amgen Inc. | 3 | $63 |
| SANOFI-AVENTIS U.S. LLC | 3 | $50 |
| Lundbeck LLC | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Surmodics, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: TZIELD, Ozempic, MOUNJARO, REXULTI, Kerendia, TAVNEOS, JARDIANCE, OTEZLA.
Industry payments across TX — which companies pay providers there.
